Naïve T lymphocytes display weaker and slower responses than antigen-experienced cells for reasons that are not well understood. Here we show that T-cell receptor (TCR) stimulation induces distinct ERK and p38 phosphorylation patterns in naïve and antigen-experienced human T cells, and that these contribute to the differential responses shown by these cells. Specifically, TCR ligation triggers the activation of the ERK pathway in naïve cells. This phosphorylation of ERK attenuates subsequent calcium influx and accelerates the degradation of the signalsome. In contrast, anti-CD3 stimulation of experienced cells results in the phosphorylation of p38 via an association with Discs large (Dlg). Thus, there are distinct signaling pathways triggered by TCR ligation that impair signaling in naïve cells and facilitate it in antigen-experienced cells.
Naïve T lymphocytes display weaker and slower responses than antigen-experienced cells for reasons that are not well understood. Here we show that T-cell receptor (TCR) stimulation induces distinct ERK and p38 phosphorylation patterns in naïve and antigen-experienced human T cells, and that these contribute to the differential responses shown by these cells. Specifically, TCR ligation triggers the activation of the ERK pathway in naïve cells. This phosphorylation of ERK attenuates subsequent calcium influx and accelerates the degradation of the signalsome. In contrast, anti-CD3 stimulation of experienced cells results in the phosphorylation of p38 via an association with Discs large (Dlg). Thus, there are distinct signaling pathways triggered by TCR ligation that impair signaling in naïve cells and facilitate it in antigen-experienced cells.
T-cell signaling
A principal function of most T cells is to respond to specific foreign antigens while maintaining self-tolerance. Central to that process is the binding of the T-cell receptor (TCR) to specific peptides bound to molecules of the major histocompatibility complex expressed on antigen-presenting cells (APCs). Once TCR engages its ligand, the ζ-chain-associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, initiating several signaling cascades (1) (2) (3) (4) (5) . However, it remains poorly understood how the signals are selectively directed toward distinct downstream pathways to effect particular outcomes in different T lymphocytes. In other signaling systems, in which common signaling molecules are selectively channeled toward one of several available downstream pathways, scaffolding proteins play a crucial role in signaling pathway selection (6) (7) (8) .
Zap-70 activation induces recruitment and activation of scaffold molecules such as the linker of activated T cells (LAT) and SH2 domain containing leukocyte protein of 76 kDa (SLP-76). These molecules play crucial roles in spatial and temporal regulation of the formation of immunological synapses at the Tcell-APC interface (9) (10) (11) (12) (13) . Enzymatically active transducers, including phosphatidylinositol-3-OH kinase and phospholipase Cγ1, activate enzymatic signaling cascades and change conformations and binding capacities of signaling molecules, facilitating the formation of multimolecular signalsomes, which relay signals downstream. These signals lead to the activation of transcription factors, such as nuclear factor of activated T cells (NFAT) and NF-κB, and ultimately regulate T-cell development, activation, and effector function (1, 3, 5, 14, 15) .
MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses (1, 5, 16) . In particular, the ERK pathway is one of the important MAP kinase pathways. Upon stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential three-part protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK). Multiple ERK MAP3Ks have been identified, including members of the Raf family. MAPKK1 and MAPKK2 are the primary MAPKKs in this pathway (17, 18) . The ERK pathway is reported to play an important role in the regulation of T-cell activation and differentiation, including Th2 differentiation (19) . Another pivotal MAPK pathway in activated T cells involves p38, which is thought to be phosphorylated by MAPKK3 and MAPKK6 (20, 21) . Meanwhile, an alternative, human discs large (hDLg)-dependent but MAPKKs-independent mechanism of p38 activation has been identified in TCR-stimulated mouse T cells, and that pathway leads to NFAT activation and the production of certain cytokines, such as IL-2 and IFN-γ (10, 22, 23) . In the alternative p38 pathway of mouse T cells, hDlg forms complexes not only with p38 but also with Lck and Zap-70 and induces p38 activation upon TCR ligation. Mice deficient in the growth-arrest gene Gadd45α, which fail to down-regulate the alternative p38 pathway, exhibit T-cell hyperproliferation and autoimmunity, suggesting the importance of this pathway (24) . Although both in ERK and in the alternative p38 pathway, Zap-70 forms signalsomes, the components are different, and it is not yet well understood how the proximal TCR signals are split toward these independently controlled downstream pathways via Zap-70.
Despite this wealth of information about TCR-activated signaling pathways, it is still not understood why the response time of naïve T cells is much slower and its magnitude is less robust than that of experienced cells. Here we demonstrate that the balance between ERK and p38 phosphorylation is dramatically different in naïve and experienced human T cells after TCR stimulation and that this could explain the difference in their responses. In addition, we provide evidence for the importance of SLP-76 and hDlg in converting TCR stimulation into specific signals involving Zap-70.
Results
Differential ERK and p38 Phosphorylation in TCR-Stimulated Naïve Cells vs. Antigen-Experienced T Cells. We first focused on the ERK signaling and analyzed whether there were any differences in its phosphorylation levels between naïve and experienced T-cell populations. In both CD4 + and CD8 + T cells, 2 min of treatment with CD3 and CD28 cross-linking induced optimal ERK phosphorylation ( Fig. 1A and Fig. S1A ), and this response waned after 5 min (Fig. S1B) . As expected, pretreatment with U0126, a specific inhibitor of ERK pathway, diminished the ERK activation (Fig. S1C) . When the T-cell populations were subdivided into naïve and experienced populations with CD45RA and CD45RO, respectively, the level of ERK phosphorylation in the naïve population was much higher than that in the antigen-experienced population ( Fig. 1 B and C, Fig. S1 D and E, and Fig. S2 ). Using an anti-CD3 antibody that targets a different epitope gave the same trends ( Fig. 1D and Fig. S1F ). These results show that TCR We next analyzed p38 phosphorylation because it is another major constituent of the MAPK family and has been reported to be one of the key molecules governing T-cell fate after the recognition of its antigen (20, 21) . As shown in Fig. 2A and Fig. S3A , and similar to the ERK results, p38 was phosphorylated in both CD4 + and CD8 + T cells stimulated by cross-linking for 2 min, and this phosphorylation reaction was almost gone after 5 min (Fig. S3B) . Consistent with previous results (22) , TCR ligationinduced p38 activation was significantly inhibited by SB203580, a p38-specific inhibitor (Fig. S3C ). However, in marked contrast to ERK phosphorylation, phosphorylated p38-positive cells were predominantly distributed in the antigen-experienced population ( Last, we also stimulated T cells with the superantigen staphylococcal enterotoxin A (SEA), which polyclonally activates Vβ 1 -expressing CD4 + T cells through the TCR. CD4 + T cells were mixed with SEA-pulsed, autologous dendritic cells, and 4 min of stimulation conferred optimal phosphorylation of ERK and p38 on the CD4 + Vβ 1 + cells (Fig. S4) . As with the anti-CD3 stimulation ( Fig. 3 A and B) , phospho-ERK predominated in the naïve T-cell population, and p38 was phosphorylated preferentially in experienced cells ( cells (Fig. S7) . Thus, SLP-76 may be involved in the ERK phosphorylation in naïve vs. experienced cells.
We also assessed the involvement of hDlg, another scaffolding protein that is known to regulate p38 in activated T cells (27) . We analyzed the capability of hDlg to associate with p38 and to induce its phosphorylation in naïve or memory CD4 + T cells upon TCR stimulation. As shown in Fig. 5 A and B, without stimulation, hDlg neither associated with nor phosphorylated p38 in either T-cell population, indicating that those molecules are not constitutively associated in human T cells. However, upon stimulation, not only the association between hDlg and p38 but also the activation of p38 was observed specifically in antigenexperienced T cells (Fig. 5B) . Additionally, as shown in Fig. 5C ,
Because it has been reported that an alternative, hDlg-dependent p38 activation in murine T cells leads to IFN-γ production (10, 22, 23) , we analyzed the INF-γ production of TCR-stimulated cells in the presence of SB203580. As shown in Fig. S8 , p38 inhibition resulted in considerable suppression of cytokine production, indicating that the p38 activation induced by TCR ligation is involved in IFN-γ production. Taken together, these results indicate that hDlg most likely plays an important role in the phosphorylation of p38 in the experienced T-cell population.
ERK Phosphorylation
+ T cells (Fig. 6A) , and therefore we focused on CD4 + T cells. To evaluate the effect of ERK phosphorylation, we used two kinds of chemical inhibitors, U0126 and PD98059. Unstimulated cells pretreated with DMSO, U0126, or PD98059 displayed little difference in their background levels of Ca 2+ flux (Fig. 6B) . Upon TCR stimulation, in naïve cells, a clearly enhanced Ca 2+ influx was observed in ERK inhibitor-pretreated cells as compared with DMSO-treated cells (Fig. 6 B and C) . However, as expected, ERK inhibitor pretreatment induced little or no augmented Ca 2+ influx in experienced cells, showing that the influence of ERK phosphorylation upon the Ca 2+ influx in experienced cells was less than in naïve cells (Fig. 6 B and C) . These results demonstrate that ERK phosphorylation negatively regulates the TCR-induced Ca 2+ influx in naïve CD4 + T cells. In a previous report using an in vitro assay and Jurkat cells, it was suggested that the phosphorylation of ERK causes an instability in T-cell signalsomes (28) and that the phosphorylation of SLP-76 plays an important role in mediating calcium influx (26, 29) . Thus, we examined the capability of phophorylated ERK to mediate the degradation of the signalsome consisting of LAT and phospho-SLP-76 in naïve CD4 + T cells. Cells were pretreated with DMSO or U0126 before stimulation. As shown in Fig. 6D , no + experienced or naïve cells were negatively enriched by magneticactivated cell sorting and stimulated with 10 μg/mL anti-CD3ε (S4.1) and 5 μg/mL anti-CD28 (αCD3 + αCD28 crosslink) for 2 min (B). Lysates were immunoprecipitated (IP) with anti-hDlg. Wholecell lysate was also loaded (A). (C) Phosphorylation of p38 in naïve or experienced cells was quantitatively compared with the normalized values that were calculated as follows; the intensity of ppp38 band/that of the corresponding hDlg band. Data are representative of four independent experiments (A and B) and represent the mean + SD (C).
signalsome formation was detected before stimulation, but after 1.75 min of stimulation a signalsome was induced. Whereas degradation of the signalsome began in DMSO-pretreated cells at 3.5 min, U0126 seemed to prevent the degradation. These results suggest that ERK phosphorylation accelerates the degradation of the signalsome in primary human T cells. All of the results, taken together, suggest that the phosphorylation of ERK acts as a negative regulator of TCR signaling in human naïve T cells and may help to explain the reduced reactivity of these cells.
Discussion
It is well known that antigen-naïve and -experienced T cells show quite different responses to TCR stimulation. In general, experienced cells show rapid and vigorous responses, such as proliferation and cytokine production, compared with the reactions of naïve cells, which are slower and weaker. However, the molecular basis for these differences between naïve and experienced cells remains to be understood.
In this report, we show a number of striking differences in the signaling events between naïve and experienced human T cells that helps to explain these differences in responsiveness. In this study, we show that the activation of naïve cells favors the ERK pathway compared with an hDlg-dependent, alternative p38 activation in antigen-experienced T cells. As a result of ERK phosphorylation, calcium elevation is attenuated in naïve cells. In addition, activated ERK accelerates the degradation of the LAT and SLP-76 signalsome, both of which are in the ERK pathway. This means that a negative feedback loop is triggered in TCR-stimulated naïve cells through the phosphorylation of ERK. By linking hDlg-dependent p38 phosphorylation to NFAT activation and production of cytokines such as IL-2 and IFN-γ (10, 22), we show here that experienced T cells use a very different signaling pathway compared with naïve cells after TCR stimulation.
p38 is activated in two ways: first by the conventional phosphorylation of Thr180 and Tyr182 by MAPKK3 and MAPKK6 and second by an hDlg-dependent, MKK-independent mechanism upon TCR stimulation (22, 23, 27) , with this second pathway playing a crucial role in the regulation of T-cell activity (24) . In OT-1 TCR-transgenic mouse T cells, the constitutive association of p38 and hDlg has been observed (22) . However, we demonstrate that those two molecules are not constitutively associated in human T cells and that the association and phosphorylation of p38 was preferentially induced in the experienced population after TCR stimulation. In this second, alternative activation pathway, hDlg-p38 association induces the phosphorylation of p38 at Tyr323, and this phosphorylation in turn induces autophosphorylation. This results in the complete acti- vation of p38, which leads to production of IFN-γ and to the activation of NFAT, although how alternatively activated p38 affects NFAT activation remains to be determined. Here we show that TCR ligation-induced p38 activation plays a role in IFN-γ production and that hDlg may play an important role in p38 activation, although we do not exclude a contribution of the conventional pathway. In naïve cells, both p38 activation and the association between hDlg and p38 are relatively rare. It also remains to be elucidated why hDlg can associate with p38 in experienced cells but not in naïve cells. One possible reason could be differences in the location of molecules participating in the hDlg signaling complex between naïve and antigen-experienced T cells. It is well known that some molecules display a nonpolarized distribution without TCR stimulation and accumulate at the synapse formed by the T cell after stimulation. Microscopic analysis of T-cell membranes, such as high-speed photoactivated localization microscopy or transmission electron microscopy, should help in understanding this issue (30, 31) .
hDlg is a member of the MAGUK family, molecules of which contain multiple domains participating in protein-protein interactions. Through these domains, MAGUKs function as scaffolding proteins by recruiting signaling molecules to assemble multimolecular signaling complexes, and play key roles within cell-cell junctions, such as the neuronal synapse, which shares several important features with the immunological synapse (32) (33) (34) . Upon TCR ligation, hDlg is recruited to the TCR/CD28 engagement site (10) and works as a signal transducer together with Lck, Zap70, WASp, and p38. As we have shown in this study, hDlg and p38 are associated specifically in antigen-experienced but not in naïve T cells, suggesting that the hDlg complexes are only formed in experienced cells. Lck and WASp are reported to mediate actindriven immunological synapse assembly and Il-2 transcription (35) (36) (37) (38) . Collectively, the efficient induction of immunological synapses through hDlg complex formation could also be responsible for the more efficient responsiveness of antigen-experienced T cells, in addition to activation of NFAT, one of the important transcription factors for these cells (1, 39, 40) .
Here we have demonstrated that phospho-ERK acts as negative regulator of the initial T-cell responses. Interestingly, it was recently reported that T cells of rheumatoid arthritis (RA) patients show higher levels of ERK phosphorylation than those of healthy volunteers; and ERK phosphorylation in RA patients has been shown to delay tyrosine-protein phosphatase nonreceptor type 6 (SHP-1) recruitment to the immunological synapse and sustain TCR-induced Zap-70 and NF-κB signaling (41) . Therefore, ERK and LAT may be attractive therapeutic targets in RA. Similar to the human cells described here, antigen-naïve T cells and experienced T cells from mice also displayed biases in the phosphorylation of ERK or p38 upon TCR ligation (Fig. S9) . Previous studies reveal that activated ERK has the capacity to associate with LAT and to induce LAT phosphorylation at Thr155 in TCR-stimulated T cells. Thr155 phosphorylation is crucial for the attenuation of T cell signaling in human cells (28) . However, mouse LAT does not contain the Thr residue corresponding to human Thr155 (28) . Thus, the phosphorylation of ERK in mice upon TCR stimulation likely produces a different outcome than in humans. Consistent with our hypothesis, ERK activation in mouse primary T cells mediates long-lasting signaling by preventing SHP-1 recruitment to the TCR (42) . Because naïve T cells from mice, like human cells, show poor reactivity as compared with experienced cells, another negative regulatory mechanisms must exist in that species.
The best-characterized TCR-mediated NFAT activation pathway involves the calcium-dependent phosphatase calcineurin (1, 40, 43) . As we have demonstrated in this study, phosphorylation of ERK attenuates Ca 2+ influx in naïve cells upon TCR ligation, suggesting that NFAT activation would be negatively regulated by phosphorylated ERK in naïve cells. Because NFAT plays a key role in several T-cell functions (1, 39, 40) , insufficient NFAT activation may be another mechanism underlying poor reactivity in naïve T cells.
Although, in this study, we described the negative regulatory function of phospho-ERK in TCR-stimulated T cells, ERK has multiple functions in T cells (16, 19, 44) . As previously reported, ERK activation is indispensable for the production of several cytokines by TCR-stimulated T cells (45, 46) , suggesting a positive regulatory function of ERK. In those reports, T cells are exposed to long-term stimulation (>12 h), in contrast with our very brief stimulation protocol (<5 min). In long-term stimulations, it seems likely that the initial response will be modulated by subsequent signaling effects (47) and secreted cytokines triggering other receptors.
Zap-70 binds to the intracellular portion of CD3ζ and is phosphorylated in TCR-stimulated cells. Both in CD4 + and CD8 + T cells, a skewed distribution of cells positive for phosphoZap-70 was not observed in either naïve or in experienced T cells (Fig. S10) . These results indicate that the phosphorylation of Zap-70 cannot account for the ERK/p38 bias. Moreover, these data also suggest that the proximal TCR signal is shared by both the ERK pathway and the alternative p38 activation pathway. Therefore, our findings demonstrate that SLP-76 and hDlg play important roles as selective channels of proximal TCR signaling. If Zap-70 associates with SLP-76, the signal is directed toward the ERK activation pathway, resulting in the attenuation of the initial response. In contrast, if Zap-70 binds to hDlg, the signal propagates toward the alternative p38 activation pathway, resulting in more efficient activation. These findings collectively emphasize the pivotal roles of SLP-76 and hDlg as regulators of TCR signal specificity and T-cell activation by organizing the signalsomes at the TCR site.
In most of the experiments in this report, human primary T cells were stimulated in vitro with antibodies, in a very small reaction volume, in 37°C water bath. This stimulation system minimizes the time lag for initiating cell reactions, and this may explain some of the differences between the results reported here and those in the literature (48, 49) .
In summary, these data provide important insights into the signaling differences between naïve and antigen-experienced T cells that help to explain at least some of the differences in their response to activation. These results also highlight the role of molecules in these respective pathways that may be targeted to enhance or attenuate the responses of these types of T lymphocytes.
Methods
Human Peripheral Blood Mononuclear Cells. Healthy human blood was obtained from the Stanford Blood Center, and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque PLUS gradient centrifugation (GE Healthcare). All experiments followed an approved protocol of the Stanford Bloodborne Pathogens Program.
Phosphoflow Analysis. Phosphoflow technology was used to monitor phosphorylation of several signaling molecules. See SI Methods for details.
Stimulation with SEA-Pulsed Dendritic Cells. Dendritic cells used as APCs were generated from PBMCs. See SI Methods for details.
Ca
2+ Mobilization. Ca 2+ mobilization experiments were performed as described in SI Methods.
Immunoprecipitation. Immunoprecipitation was conducted as described in SI Methods.
Western Blotting. Standard methods were used (SI Methods).
Statistics. All data are shown as mean values. Significance between the control group and a treated group was examined with the unpaired Student's t test. P values of <0.05 were considered significant.
